HAMILTON LANE INC-CLASS A
HLNENASDAQ๐ #1363 by market capEarnings Nov 3US Equity
$85.87โฒ $0.92 (+1.07%)
๐ After hours$85.87โฒ 0.00%Regular close ยท extended-hours price shownTrack HLNE
Get earnings, price moves & breaking news on Telegram
24hโฒ 1.1%
7dโ
14dโ
30dโ
ytdโ
1yโ
๐ฆMarket Cap
$4.74B
Small Cap
๐Revenue Growth (YoY)
+24.0%
Healthy
๐Gross Margin
โ
๐ตFCF Margin
42.7%
Strong
โ๏ธP/S Ratio
5.4x
Fair
Otter Score
56
Weak
HAMILTON LANE INC-CLASS A
HLNEAnalyst Ratings
Price
$85.87
Total
10
Raised
0
Lowered
1
Avg PT
$131.60
H / L
$182 / $94
| Institution | Action | Rating | Date | Upside | |
|---|---|---|---|---|---|
Oppenheimer | Reiterated | Outperform | 2026-08-27 | $182.00 | +111.90% |
Keefe, Bruyette & Woods | Reiterated | Outperform | 2026-08-05 | โ | โ |
UBS | Reiterated | Buy | 2026-08-05 | $131.00 | +52.60% |
Morgan Stanley | Reiterated | Equal Weight | 2026-07-21 | $123.00 | +43.20% |
Goldman Sachs | Reiterated | Buy | 2026-06-30 | $128.00 | +49.10% |
BMO Capital | Reiterated | Outperform | 2026-05-22 | $94.00 | +9.50% |
JP Morgan | Reiterated | Overweight | 2026-05-18 | โ | โ |
Wells Fargo | Reiterated | Equal Weight | 2025-07-11 | $78.00 | โ9.20% |
William Blair | Reiterated | Outperform | 2020-02-07 | โ | โ |
Keefe Bruyette & Woods | Downgraded | Market Perform โ Underperform | 2019-07-11 | โ | โ |
Institution
Oppenheimer
Reiterated ยท Outperform ยท 2026-08-27
$182.00
+111.90%
Keefe, Bruyette & Woods
Reiterated ยท Outperform ยท 2026-08-05
โ
โ
UBS
Reiterated ยท Buy ยท 2026-08-05
$131.00
+52.60%
Morgan Stanley
Reiterated ยท Equal Weight ยท 2026-07-21
$123.00
+43.20%
Goldman Sachs
Reiterated ยท Buy ยท 2026-06-30
$128.00
+49.10%
BMO Capital
Reiterated ยท Outperform ยท 2026-05-22
$94.00
+9.50%
JP Morgan
Reiterated ยท Overweight ยท 2026-05-18
โ
โ
Wells Fargo
Reiterated ยท Equal Weight ยท 2025-07-11
$78.00
โ9.20%
William Blair
Reiterated ยท Outperform ยท 2020-02-07
โ
โ
Keefe Bruyette & Woods
Downgraded ยท Market Perform โ Underperform ยท 2019-07-11
โ
โ
One row per institution ยท price target from the firm's latest published target